Table 2 Comparison of clinical factors between ST764-MRSA-SCCmecII and other clones
ST764-MRSA-SCCmecII (n = 25) | Others (n = 555) | p-value | All (n = 580) | |
|---|---|---|---|---|
Median age (IQR) | 80 (78–88) | 76 (64–85) | 0.026 | 77 (65-85) |
Male sex (%) | 16 (64%) | 340 (61%) | n.s. | 356 (61%) |
Diabetes | 7 (28%) | 151 (27%) | n.s. | 158 (27%) |
Hemodialysis | 4 (16%) | 49 (9%) | n.s. | 53 (9%) |
Surgery within 30 days before blood culture | 3 (12%) | 48 (9%) | n.s. | 51 (9%) |
Artificial respirator use | 2 (8%) | 40 (7%) | n.s. | 42 (7%) |
Atopic dermatitis | 0 (0%) | 17 (4%) | n.s. | 17 (3%) |
Death within 30 days of hospitalization | 12 (48%) | 122 (22%) | 0.0088 0.04a | 134 (23%) |
